Achilles Therapeutics (ACHL) News Today $1.48 0.00 (0.00%) As of 03/26/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Achilles Therapeutics (ACHL) Projected to Announce Quarterly Earnings on ThursdayMarch 27, 2025 | americanbankingnews.comAchilles Therapeutics (ACHL) Projected to Post Quarterly Earnings on ThursdayAchilles Therapeutics (NASDAQ:ACHL) will be releasing earnings before the market opens on Thursday, April 3, Financial Modeling Prep reports.March 27, 2025 | marketbeat.comAchilles Therapeutics plc (NASDAQ:ACHL) Short Interest UpdateAchilles Therapeutics plc (NASDAQ:ACHL - Get Free Report) was the target of a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 478,300 shares, a decline of 40.1% from the February 13th total of 797,900 shares. Approximately 1.3% of the company's shares are short sold. Based on an average daily volume of 1,070,000 shares, the days-to-cover ratio is presently 0.4 days.March 15, 2025 | marketbeat.comAchilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC DeregistrationFebruary 28, 2025 | markets.businessinsider.comAchilles Therapeutics announces voluntary Nasdaq delisting, SEC deregistrationFebruary 28, 2025 | markets.businessinsider.comAchilles Therapeutics plc (NASDAQ:ACHL) Short Interest Up 1,280.4% in FebruaryAchilles Therapeutics plc (NASDAQ:ACHL - Get Free Report) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 797,900 shares, an increase of 1,280.4% from the January 31st total of 57,800 shares. Approximately 2.1% of the company's stock are sold short. Based on an average trading volume of 764,400 shares, the days-to-cover ratio is presently 1.0 days.February 28, 2025 | marketbeat.comShort Interest in Achilles Therapeutics plc (NASDAQ:ACHL) Drops By 52.8%Achilles Therapeutics plc (NASDAQ:ACHL - Get Free Report) was the recipient of a large decrease in short interest in January. As of January 31st, there was short interest totalling 57,800 shares, a decrease of 52.8% from the January 15th total of 122,400 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 620,100 shares, the days-to-cover ratio is currently 0.1 days.February 13, 2025 | marketbeat.comAchilles Transfers Technology Assets From TRACERx NSCLC Study To AstraZeneca For $12 Mln, Stock UpDecember 24, 2024 | markets.businessinsider.comAchilles Therapeutics Announces Sale of Technology Assets to AstraZenecaDecember 24, 2024 | globenewswire.comAchilles Therapeutics PLC: Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital MarketNovember 19, 2024 | finanznachrichten.deAchilles Therapeutics Receives Approval to Transfer to Nasdaq Capital MarketNovember 19, 2024 | globenewswire.comAchilles Therapeutics PLC: Achilles Therapeutics Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | finanznachrichten.deAchilles Therapeutics reports Q3 EPS (48c) vs. (42c) last yearNovember 14, 2024 | markets.businessinsider.comAchilles Therapeutics Explores Strategic Options Amid Financial UpdateNovember 14, 2024 | markets.businessinsider.comAchilles Therapeutics Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Edge Higher in Monday TradingSeptember 24, 2024 | msn.comAchilles Therapeutics PLC: Achilles Therapeutics Announces Strategic UpdateSeptember 19, 2024 | finanznachrichten.deAchilles Therapeutics to Lay Off Staff as Part of Review, Discontinues Drug TrialsSeptember 19, 2024 | marketwatch.comAchilles Therapeutics ADRs Rise 32% on Cost-Cutting MeasuresSeptember 19, 2024 | marketwatch.comAchilles Therapeutics Discontinues TIL-based CNeT ProgramSeptember 19, 2024 | markets.businessinsider.comAchilles climbs after decision to find strategic alternativesSeptember 19, 2024 | msn.comAchilles Therapeutics Shares Are Trading Higher: What You Need To KnowSeptember 19, 2024 | msn.comAchilles Therapeutics Announces Strategic UpdateSeptember 19, 2024 | globenewswire.comAchilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business UpdatesAugust 14, 2024 | globenewswire.comAchilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer VaccinesMay 22, 2024 | globenewswire.comAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementMay 17, 2024 | globenewswire.comACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024May 8, 2024 | investorplace.comAchilles Therapeutics PLC: Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 8, 2024 | finanznachrichten.deAchilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 8, 2024 | globenewswire.comAchilles Therapeutics plc - Depositary Receipt () (ACHL) Price Target Decreased by 56.41% to 2.89April 17, 2024 | msn.comPiper downgrades Achilles to neutral, cites latest dataApril 5, 2024 | msn.comACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023April 4, 2024 | markets.businessinsider.comAchilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | finanznachrichten.deAchilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | globenewswire.comAchilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host ConditioningApril 4, 2024 | globenewswire.comAchilles Therapeutics (ACHL) to Release Earnings on TuesdayAchilles Therapeutics (NASDAQ:ACHL) will be releasing earnings on Tuesday, April 2, Yahoo Finance reports.April 1, 2024 | marketbeat.comWill Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?March 7, 2024 | finance.yahoo.comAchilles Therapeutics (ACHL) Set to Announce Quarterly Earnings on TuesdayAchilles Therapeutics (NASDAQ:ACHL) will be releasing earnings on Tuesday, March 5, Yahoo Finance reports.March 4, 2024 | marketbeat.comAchilles Therapeutics PLC ADRFebruary 22, 2024 | wsj.comAchilles Therapeutics Stock (NASDAQ:ACHL), Short Interest ReportFebruary 22, 2024 | benzinga.comAchilles Therapeutics PLC ADR (ACHL)February 9, 2024 | investing.comAchilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 ConferenceFebruary 5, 2024 | finance.yahoo.comAchilles Therapeutics Stock (NASDAQ:ACHL) Dividends: History, Yield and DatesDecember 22, 2023 | benzinga.comACHL Achilles Therapeutics plcDecember 20, 2023 | seekingalpha.comAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity PredictionDecember 18, 2023 | finance.yahoo.comSteelers lose Kwon Alexander for season with torn Achilles: reportsNovember 22, 2023 | foxnews.comAchilles Therapeutics GAAP EPS of -$0.42 misses by $0.02November 14, 2023 | msn.comAs Aaron Rodgers rehabs from torn Achilles, doctor offers insight into recoveryOctober 29, 2023 | foxnews.comAchilles Therapeutics PLC: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementSeptember 23, 2023 | finanznachrichten.deAre Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?September 22, 2023 | uk.style.yahoo.com Remove Ads Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address ACHL Media Mentions By Week ACHL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACHL News Sentiment▼0.000.61▲Average Medical News Sentiment ACHL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACHL Articles This Week▼00▲ACHL Articles Average Week Remove Ads Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ENGN News FHTX News YMAB News NVCT News KRRO News INMB News TVGN News VYGR News ELDN News INBX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACHL) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACHL Stock Free ACHL Stock Alerts